Journal Article

Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

Sulyok, Mihály, Manoj, Anita, Richie, Thomas L., Held, Jana, Gmeiner, Markus, James, Eric R., Ishizuka, Andrew S., Li, Tao, Li, Minglin, Seder, Robert A., Chakravarty, Sumana, Eappen, Abraham G., Lagler, Heimo, Natasha, KC, Felgner, Phil L., Surat, Güzin, Mengue, Juliana B., Calle, Carlos Lamsfus, Stafford, Richard E., Murshedkar, Tooba, Sim, B. Kim Lee, Esen, Meral, Gebru, Tamirat, Lalremruata, Albert, Kremsner, Peter G., Gunasekera, Anusha, Mordmüller, Benjamin, Hoffman, Stephen L., Campo, Joseph J., Billingsley, Peter F., Ibáñez, Javier, Ruben, Adam J.

2017

Overview

Immunization with Plasmodium falciparum sporozoites under chemoprophylaxis can protect against controlled human malaria infection with the same strain for at least 10 weeks, and protection correlates with polyfunctional T-cell memory. The search for a malaria vaccine The best candidates for a malaria vaccine so far have been radiation-attenuated Plasmodium falciparum sporozoites (PfSPZ) inoculated by mosquitos, intravenous injection of radiation-attenuated, cryopreserved PfSPZ, and infectious PfSPZ inoculated by mosquitos in people taking chloroquine or mefloquine. Here Stephen Hoffman, Peter Kremsner and colleagues report that inoculation of volunteers taking chloroquine with direct intravenous injection of aseptic, cryopreserved, non-irradiated PfSPZ can induce protection against infection with the same strain for at least ten weeks. The authors show that protection correlates with polyfunctional T-cell memory. A highly protective malaria vaccine would greatly facilitate the prevention and elimination of malaria and containment of drug-resistant parasites 1 . A high level (more than 90%) of protection against malaria in humans has previously been achieved only by immunization with radiation-attenuated Plasmodium falciparum (Pf) sporozoites (PfSPZ) inoculated by mosquitoes 2 , 3 , 4 ; by intravenous injection of aseptic, purified, radiation-attenuated, cryopreserved PfSPZ (‘PfSPZ Vaccine’) 5 , 6 ; or by infectious PfSPZ inoculated by mosquitoes to volunteers taking chloroquine 7 , 8 , 9 , 10 or mefloquine 11 (chemoprophylaxis with sporozoites). We assessed immunization by direct venous inoculation of aseptic, purified, cryopreserved, non-irradiated PfSPZ (‘PfSPZ Challenge’ 12 , 13 ) to malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ-CVac) 14 . Three doses of 5.12 × 10 4 PfSPZ of PfSPZ Challenge 12 , 13 at 28-day intervals were well tolerated and safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria infection ten weeks after the last dose (group III). Protective efficacy was dependent on dose and regimen. Immunization with 3.2 × 10 3 (group I) or 1.28 × 10 4 (group II) PfSPZ protected 3 out of 9 (33%) or 6 out of 9 (67%) volunteers, respectively. Three doses of 5.12 × 10 4 PfSPZ at five-day intervals protected 5 out of 8 (63%) volunteers. The frequency of Pf-specific polyfunctional CD4 memory T cells was associated with protection. On a 7,455 peptide Pf proteome array, immune sera from at least 5 out of 9 group III vaccinees recognized each of 22 proteins. PfSPZ-CVac is a highly efficacious vaccine candidate; when we are able to optimize the immunization regimen (dose, interval between doses, and drug partner), this vaccine could be used for combination mass drug administration and a mass vaccination program approach to eliminate malaria from geographically defined areas.

• Publisher: Nature Publishing Group UK,Nature Publishing Group
• Subject: 631/250/255/1629 / 631/250/590/1867 / Adolescent / Adult / Antibodies, Protozoan - blood / Antibodies, Protozoan - immunology / Aquatic insects / Automation / Chloroquine - therapeutic use / Dosage and administration / Double-Blind Method / Drug dosages / Healthy Volunteers / Humanities and Social Sciences / Humans / Immunization / Immunoglobulins / Immunologic Memory - immunology / Infections / letter / Liver / Lymphocytes / Malaria / Malaria vaccines / Malaria Vaccines - administration & dosage / Malaria Vaccines - immunology / Malaria, Falciparum - blood / Malaria, Falciparum - immunology / Malaria, Falciparum - parasitology / Malaria, Falciparum - prevention & control / Middle Aged / Mosquitoes / multidisciplinary / Parasites / Plasmodium falciparum - classification / Plasmodium falciparum - immunology / Prevention / Proteins / Science / Sporozoites - immunology / T-Lymphocytes - immunology / Time Factors / Vaccines / Vaccines, Attenuated - administration & dosage / Vaccines, Attenuated - immunology / Vector-borne diseases / Young Adult